Literature DB >> 8606800

Anatoxin-a-evoked [3H]dopamine release from rat striatal synaptosomes.

L Soliakov1, T Gallagher, S Wonnacott.   

Abstract

Presynaptic nicotinic acetylcholine receptors on striatal nerve terminals modulate the release of dopamine. Using rat striatal synaptosomes loaded with [3H]dopamine, we have characterized the action of the selective nicotinic agonist, (+/-)anatoxin-a, with respect to [3H]dopamine release, in order to explore the mechanisms coupling nicotinic receptor activation to exocytosis. Anatoxin-a evoked [3H]dopamine release in a concentration-dependent and mecamylamine-sensitive manner, EC50 = 0.11 microM. The maximum [3H]dopamine release elicited by anatoxin-a was only 20% of the maximum elicited by KCl depolarization; there was no additivity between anatoxin-a and sub-maximal concentrations of KCl. Both agents stimulated Ca(2+)-dependent release that was equally sensitive to inhibition by 200 microM Cd2+. This result suggests that anatoxin-a-stimulated exocytosis is mediated by Ca2+ influx via voltage-sensitive Ca2+ channels, with little contribution from Ca2+ entering directly through the nicotinic receptor channel. This view is supported by the abolition of anatoxin-a-evoked [3H]dopamine release in Na(+)-depleted medium. A partial (40%) inhibition by tetrodotoxin was observed. These data suggest that activation of presynaptic nicotinic acetylcholine receptors by anatoxin-a results in an influx of Na+, producing sufficient local depolarization to open voltage-sensitive Ca2+ and Na+ channels. The latter may then amplify the response, activating further Ca2+ channels. The particular voltage-sensitive Ca2+ channels involved remain to be determined.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8606800     DOI: 10.1016/0028-3908(95)00122-m

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  15 in total

Review 1.  Neurotransmitter release mechanisms in sympathetic neurons: past, present, and future perspectives.

Authors:  V M Jackson; T C Cunnane
Journal:  Neurochem Res       Date:  2001-09       Impact factor: 3.996

Review 2.  Muscarinic and nicotinic acetylcholine receptor agonists and allosteric modulators for the treatment of schizophrenia.

Authors:  Carrie K Jones; Nellie Byun; Michael Bubser
Journal:  Neuropsychopharmacology       Date:  2011-09-28       Impact factor: 7.853

3.  In vivo effects of the anatoxin-a on striatal dopamine release.

Authors:  F Campos; R Durán; L Vidal; L R F Faro; M Alfonso
Journal:  Neurochem Res       Date:  2006-05-09       Impact factor: 3.996

4.  Involvement of protein kinase C in the presynaptic nicotinic modulation of [(3)H]-dopamine release from rat striatal synaptosomes..

Authors:  L Soliakov; S Wonnacott
Journal:  Br J Pharmacol       Date:  2001-02       Impact factor: 8.739

5.  In vivo neurochemical characterization of anatoxin-a evoked dopamine release from striatum.

Authors:  F Campos; R Durán; L Vidal; L R F Faro; M Alfonso
Journal:  J Neural Transm (Vienna)       Date:  2006-08-08       Impact factor: 3.575

6.  Developmental regulation of nicotinic acetylcholine receptors within midbrain dopamine neurons.

Authors:  L Azam; Y Chen; F M Leslie
Journal:  Neuroscience       Date:  2006-12-29       Impact factor: 3.590

7.  Pharmacological characterization of a nicotinic autoreceptor in rat hippocampal synaptosomes.

Authors:  G I Wilkie; P Hutson; J P Sullivan; S Wonnacott
Journal:  Neurochem Res       Date:  1996-09       Impact factor: 3.996

8.  Catecholamine outflow from mouse and rat brain slice preparations evoked by nicotinic acetylcholine receptor activation and electrical field stimulation.

Authors:  P Scholze; A Orr-Urtreger; J-P Changeux; J M McIntosh; S Huck
Journal:  Br J Pharmacol       Date:  2007-04-02       Impact factor: 8.739

Review 9.  Mammalian nicotinic acetylcholine receptors: from structure to function.

Authors:  Edson X Albuquerque; Edna F R Pereira; Manickavasagom Alkondon; Scott W Rogers
Journal:  Physiol Rev       Date:  2009-01       Impact factor: 37.312

Review 10.  Striatal cholinergic interneurons and Parkinson's disease.

Authors:  Asami Tanimura; Tristano Pancani; Sean Austin O Lim; Cecilia Tubert; Alexandra E Melendez; Weixing Shen; Dalton James Surmeier
Journal:  Eur J Neurosci       Date:  2017-07-20       Impact factor: 3.386

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.